National Cancer Institute; Notice of Meeting, 66034 [2013-26253]

Download as PDF 66034 Federal Register / Vol. 78, No. 213 / Monday, November 4, 2013 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting TKELLEY on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the National Cancer Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance and the competence of individual investigators. Additionally for the review of grant applications and the discussions, that could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board; Ad hoc Subcommittee on Global Cancer Research. Open: December 9, 2013, 6:00 p.m. to 7:30 p.m. Agenda: Discussion on Global Cancer Research. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814. Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad hoc Subcommittee on Global Cancer Research, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W–562, Bethesda, MD 20892, (240) 276– 5796, trimblet@mail.nih.gov. Name of Committee: National Cancer Advisory Board; Ad hoc Subcommittee on Communications. Open: December 9, 2013, 7:45 p.m. to 9:15 p.m. Agenda: Discussion on Communications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814. Contact Person: Dr. Lenora Johnson, Executive Secretary, NCAB Ad hoc VerDate Mar<15>2010 17:07 Nov 01, 2013 Jkt 232001 Subcommittee on Communications, National Cancer Institute, National Institutes of Health, 9606 Medical Center Drive, Room 2E–454, Bethesda, MD 20892, (240) 276– 6680, johnslen@mail.nih.gov. Name of Committee: National Cancer Advisory Board. Open: December 10, 2013, 9:00 a.m. to 3:30 p.m. Agenda: Program reports and presentations; business of the Board. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 9606 Medical Center Drive, Room 7W–444, Bethesda, MD 20892, (240) 276–6340. Name of Committee: National Cancer Advisory Board. Closed: December 10, 2013, 3:30 p.m. to 5:00 p.m. Agenda: Review intramural program site visit outcomes. Discussion of confidential and personnel issues. Review and evaluate grant applications. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 9606 Medical Center Drive, Room 7W–444, Bethesda, MD 20892, (240) 276–6340. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: NCAB: deainfo.nci.nih.gov/advisory/ncab.htm where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS). Dated: October 29, 2013. Melanie Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–26253 Filed 11–1–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing For Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) notifies federal agencies of the Laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently certified laboratories and IITF is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at https:// www.workplace.samhsa.gov. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 7– 1051, One Choke Cherry Road, Rockville, Maryland 20857; 240–276– 2600 (voice), 240–276–2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100–71. The ‘‘Mandatory Guidelines for Federal Workplace Drug Testing Programs,’’ as amended in the revisions listed above, requires strict standards that laboratories and Instrumented Initial Testing Facilities (IITF) must meet in order to conduct SUMMARY: E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 78, Number 213 (Monday, November 4, 2013)]
[Notices]
[Page 66034]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26253]



[[Page 66034]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the 
National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public as indicated 
below in accordance with the provisions set forth in sections 
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review, 
discussion, and evaluation of individual intramural programs and 
projects conducted by the National Cancer Institute, including 
consideration of personnel qualifications and performance and the 
competence of individual investigators. Additionally for the review of 
grant applications and the discussions, that could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board; Ad hoc 
Subcommittee on Global Cancer Research.
    Open: December 9, 2013, 6:00 p.m. to 7:30 p.m.
    Agenda: Discussion on Global Cancer Research.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, Maryland 20814.
    Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad 
hoc Subcommittee on Global Cancer Research, National Cancer 
Institute, National Institutes of Health, 9609 Medical Center Drive, 
Room 3W-562, Bethesda, MD 20892, (240) 276-5796, 
trimblet@mail.nih.gov.

    Name of Committee: National Cancer Advisory Board; Ad hoc 
Subcommittee on Communications.
    Open: December 9, 2013, 7:45 p.m. to 9:15 p.m.
    Agenda: Discussion on Communications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, Maryland 20814.
    Contact Person: Dr. Lenora Johnson, Executive Secretary, NCAB Ad 
hoc Subcommittee on Communications, National Cancer Institute, 
National Institutes of Health, 9606 Medical Center Drive, Room 2E-
454, Bethesda, MD 20892, (240) 276-6680, johnslen@mail.nih.gov.

    Name of Committee: National Cancer Advisory Board.
    Open: December 10, 2013, 9:00 a.m. to 3:30 p.m.
    Agenda: Program reports and presentations; business of the 
Board.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 9606 
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.

    Name of Committee: National Cancer Advisory Board.
    Closed: December 10, 2013, 3:30 p.m. to 5:00 p.m.
    Agenda: Review intramural program site visit outcomes. 
Discussion of confidential and personnel issues. Review and evaluate 
grant applications.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 9606 
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: NCAB: deainfo.nci.nih.gov/advisory/ncab.htm where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS).

    Dated: October 29, 2013.
Melanie Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26253 Filed 11-1-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.